Abstract
The global HIV pandemic began to expand rapidly in southern Africa a decade later than was noted in central Africa, Europe, the Caribbean, and North America. Multiple factors played a role in this rapid expansion which led Southern Africa to become the most heavily afflicted region for HIV/AIDS globally. In this issue of Current HIV/AIDS Reports, investigators with active research interests in the region have reviewed key elements of the causes of and responses to the epidemic. Putative causes of the high HIV prevalence in the region are discussed, including host and viral biology, human behavior, politics and policy, structural factors, health services, health workforce, migration, traditional healers’ role, and other issues. Regional epidemiological trends are described and forecasted. Issues related to the continuum of HIV care and treatment are highlighted. We hope that the reviews will prove useful to those policymakers, health care workers, and scientists who are striving to reduce the burden of HIV in the southern African region, as well as prove insightful for key issues of broader global relevance.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Karim QA, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal. South Africa Int J Epidemiol. 2011;40:922–30.
Williams BG, Gouws E, Somse P, Mmelesi M, Lwamba C, Chikoko T, et al. Epidemiological trends for HIV in southern Africa: implications for reaching the elimination targets. Curr HIV/AIDS Rep. 2015;12:2. Modeling projections for the 8 nations of southern Africa with the largest HIV epidemics.
Simelela N, Venter WD, Pillay Y, Barron P. A political and social history of HIV in South Africa. Curr HIV/AIDS Rep. 2015;12:2. A history of the epidemic in South Africa, emphasizing its policy and political elements.
Vermund SH, Sidat M, Weil LF, Tique JA, Moon TD, Ciampa PJ. Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS. 2012;26(10):1303–10.
Bolton Moore C, Ciaraldi E. Quality of care and service expansion for HIV care and treatment. Curr HIV/AIDS Rep. 2015;12:2. Key issues in the rapid expansion of HIV services, particularly quality of care factors.
Bhardwaj S, Carter B, Aarons GA, Chi BH. Implementation research for the prevention of mother-to-child HIV transmission in sub-Saharan Africa: existing evidence, current gaps, and new opportunities. Curr HIV/AIDS Rep. 2015;12:2. A critical review of elements for PMTCT needed for elimination of transmission.
Cook RE, Ciampa PJ, Sidat M, Blevins M, Burlison J, Davidson MA, et al. Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambézia, Mozambique. J Acquir Immune Defic Syndr. 2011;56(4):e104–9.
Vermund SH, Blevins M, Moon TD, José E, Moiane L, Tique JA, et al. Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS ONE. 2014;9(10):e110116.
Kaul R, Prodger J, Joag V, Shannon B, Yegorov S, McKinnon L. Inflammation and the HIV epidemic in sub-Saharan Africa. Curr HIV/AIDS Rep. 2015;12:2. A review of key immunology and virology principles underlying the southern African HIV epidemic, notably factors that exacerbate genital and systemic inflammation.
Novitsky V, Ndung’u T, Wang R, Bussmann H, Chonco F, Makhema J, et al. Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS. 2011;25(12):1515–22.
Armbruster B, Beck EC, Waheed M. The importance of extended high viremics in models of HIV spread in South Africa. Health Care Manag Sci. 2014;17(2):182–93.
Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Ondondo R. Partners in prevention HSVHIV transmission study team. HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples. AIDS. 2014;28(2):235–43.
Campbell MS, Kahle EM, Celum C, Lingappa JR, Kapiga S, Mujugira A, et al. Partners in prevention HSV/HIV transmission study team. Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters. J Infect Dis. 2013;207(7):1166–70.
Harrison A, Colvin CJ, Kuo C, Swartz A, Lurie M. Sustained high HIV incidence in young women in southern Africa: social, behavioral and structural factors and emerging intervention approaches. Curr HIV/AIDS Rep. 2015;12:2. Concentrating on young women, a review of both antecedent contributors and potential interventions for HIV prevention in southern Africa.
Audet CM, Hamilton E, Hughart L, Salato J. Engagement of traditional healers and birth attendants as a controversial proposal to extend the HIV health workforce. Curr HIV/AIDS Rep. 2015;12:2. Within the context of the health workforce, an examination of the potential of task shifting to engaged traditional healers and traditional birth attendants.
Assefa Y, Kiflie A, Tekle B, Mariam DH, Laga M, Van Damme W. Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia. J Health Serv Res Policy. 2012;17(1):24–9.
Rasschaert F, Philips M, Van Leemput L, Assefa Y, Schouten E, Van Damme W. Tackling health workforce shortages during antiretroviral treatment scale-up—experiences from Ethiopia and Malawi. J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S109–12.
Tankwanchi ABS, Özden C, Vermund SH. Physician emigration from sub-Saharan Africa to the United States: analysis of the 2011 AMA Physician Masterfile. PLoS Med. 2013;10(9):e1001513.
Tankwanchi AB, Vermund SH, Perkins DD. Has the WHO global code of practice on the international recruitment of health personnel been effective? Lancet Glob Health. 2014;2(7):e390–1.
Silvestri DM, Blevins M, Afzal AR, Andrews B, Derbew M, Kaur S, et al. Medical and nursing students’ intentions to work abroad or in rural areas: a cross-sectional survey in Asia and Africa. Bull World Health Organ. 2014;92(10):750–9.
Sherr K, Pfeiffer J, Mussa A, Vio F, Gimbel S, Micek M, et al. The role of nonphysician clinicians in the rapid expansion of HIV care in Mozambique. J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S20–3.
Sherr K, Mussa A, Chilundo B, Gimbel S, Pfeiffer J, Hagopian A, et al. Brain drain and health workforce distortions in Mozambique. PLoS One. 2012;7:4e35840.
Audet CM, Blevins M, Rosenberg C, Farnsworth S, Salato J, Fernandez J, et al. Symptomatic HIV-positive persons in rural Mozambique who first consult a traditional healer have delays in HIV testing: a cross-sectional study. J Acquir Immune Defic Syndr. 2014;66(4):e80–6.
Audet CM, Salato J, Blevins M, Amsalem D, Vermund SH, Gaspar F. Educational intervention increased referrals to allopathic care by traditional healers in three high HIV-prevalence rural districts in Mozambique. PLoS One. 2013;8(8):e70326.
Shanaube K, Bock P. Innovative strategies for scale up of effective combination HIV prevention interventions in Sub Saharan Africa. Curr HIV/AIDS Rep. 2015;12:2. A summary of key principles for, and studies of combination prevention strategies for southern Africa, especially treatment as prevention.
Narayan KM, Miotti PG, Anand NP, Kline LM, Harmston C, Gulakowski 3rd R, et al. HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings. J Acquir Immune Defic Syndr. 2014;67 Suppl 1:S2–7.
Vermund SH, Narayan KM, Glass RI. Chronic diseases in HIV survivors. Sci Transl Med. 2014; 6(241):241ed14.
Vernazza PL, Gilliam BL, Flepp M, Dyer JR, Frank AC, Fiscus SA, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS. 1997;11(10):1249–54.
Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.
Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum. 2015;17(10):901–10.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365(6):493–505.
Holmes CB, Blandford JM, Sangrujee N, Stewart SR, DuBois A, Smith TR, et al. PEPFAR’s past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programs. Health Aff (Millwood). 2012;31(7):1553–60.
Leach-Kemon K, Chou DP, Schneider MT, Tardif A, Dieleman JL, Brooks BP, et al. The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Aff (Millwood). 2012;31(1):228–35.
El-Sadr WM, Holmes CB, Mugyenyi P, Thirumurthy H, Ellerbrock T, Ferris R, et al. Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr. 2012;60 Suppl 3:S96–104.
Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014;11(9):e1001725.
April MD, Wood R, Berkowitz BK, Paltiel AD, Anglaret X, Losina E, et al. The survival benefits of antiretroviral therapy in South Africa. J Infect Dis. 2014;209(4):491–9.
Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, et al. Effect of antiretroviral therapy on patients’ economic well being: five-year follow-up. AIDS. 2014;28(3):417–24.
Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013;91(1):70–4.
Acknowledgments
Supported, in part, by these NIH grants: UM1AI068619 (HIV Prevention Trials Network) and D43TW001035 (Vanderbilt-CIDRZ AIDS International Training and Research Program).
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Sten H. Vermund, Emily K. Sheldon, and Mohsin Sidat declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on The Global Epidemic
Rights and permissions
About this article
Cite this article
Vermund, S.H., Sheldon, E.K. & Sidat, M. Southern Africa: the Highest Priority Region for HIV Prevention and Care Interventions. Curr HIV/AIDS Rep 12, 191–195 (2015). https://doi.org/10.1007/s11904-015-0270-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-015-0270-z